Magnetic resonance imaging (MRI) for surveillance for breast cancer recurrence following mastectomy and breast reconstruction

Record ID 32014001215
English
Authors' recommendations: In the United States, an estimated 235,030 new cases of invasive breast cancer will be diagnosed in 2014, and an estimated 40,430 patients will die of the disease. Given a choice of breast-conserving surgery plus adjunct radiotherapy or mastectomy, 30% to 47% of women choose mastectomy and 27% to 65% of this group will have reconstructive surgery. In 2013, nearly 100,000 women underwent postmastectomy breast reconstruction. Reconstruction is performed using prosthetics made of saline or silicone, autologous tissue flaps (using the patient's own muscle and fat), or both. Common autologous flap techniques include the transverse rectus abdominis myocutaneous (TRAM) flap using tissue from the abdominal wall and the latissimus dorsi flap using tissue from the shoulder. Patients with a history of breast cancer are at increased risk for developing a second breast cancer as well as recurrence of the primary tumor in the ipsilateral breast; however, there is little information about whether follow-up imaging improves outcomes in patients who ndergo mastectomy and breast reconstruction. With the increasing popularity of breast reconstruction after mastectomy, there is a need to identify reliable tests for early diagnosis of potentially treatable recurrences.
Details
Project Status: Completed
Year Published: 2014
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: United States
MeSH Terms
  • Magnetic Resonance Imaging
  • Mass Screening
Contact
Organisation Name: HAYES, Inc.
Contact Address: 157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name: saleinfo@hayesinc.com
Contact Email: saleinfo@hayesinc.com
Copyright: 2014 Winifred S. Hayes, Inc
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.